Medicinova Inc. (MNOV) stock forecast and price target
Price $1.40 · data as of November 13, 2026
12-month price target
Average target$8.25
Upside / downside+491.4%
Analysts4
ConsensusNone
Low $6.00Average $8.25High $11.00
Gold marker: average target · white marker: today’s price ($1.40)
Analyst ratings
Strong buy 1Buy 3Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-0.26 | −7.0% | $730000 |
| Next fiscal year ends December 31, 2027 | $-0.52 | −100.6% | $333330 |
| Next quarter ends December 31, 2026 | $-0.08 | −60.0% | $33330 |
| Quarter after ends March 31, 2027 | $-0.08 | −60.0% | $0 |
Consensus of the analysts covering Medicinova, updated daily. In the last 30 days 0 estimates were raised and 1 lowered.
Frequently asked questions
What is the Medicinova stock price target?
The average 12-month target from 4 analysts is $8.25, 491.4% above the current price of $1.40 Targets range from $6.00 to $11.00.
Is Medicinova a buy according to analysts?
The consensus rating is “None” (1 strong buy, 3 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Medicinova expected to earn?
Analysts expect EPS of $-0.26 for the fiscal year ending December 31, 2026 and $-0.52 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.